Sleep Apnoea Breathing Record Exploratory Study (SABRES)

NCT06050720 | Completed Results DMC

• 1 other identifier: 3282
• Study Type: interventional
• Target: 40
• Locations: 1 country
• Sites: 1

Brief Summary

During sleep, many people have times when they breathe shallowly or completely stop. If a person stops breathing for more than 10 seconds, this is called an 'apnoea'. If shallow breathing lasts for more than 10 seconds, it is called a 'hypopnoea'. If a person has these events frequently, it disrupts their sleep and they do not awake refreshed. It can also put strain on the heart, leading to cardiovascular conditions. These sleep disorders, usually called 'Sleep Apnoea', can be treated for most people using 'continuous positive airways pressure', CPAP. Current tests for sleep apnoea, usually used at home, are expensive, complicated for patients to use and do not monitor actual breathing. The new test, called Apne-Scan, is very simple and will cost less than the standard tests. It just requires the user to wear a mask, similar to ones used for CPAP treatment, overnight and then send the mask off for data analysis. The Apne-Scan mask, developed with taxpayer funding, is fitted with a pressure sensor to monitor actual breathing. People between the ages of 18-70 who have been referred to the sleep clinic at Royal Stoke University Hospital are eligible to participate in this exploratory study. They will wear the Apne-Scan mask at the same time as their standard overnight sleep apnoea test. The breathing data collected by Apne-Scan will be analysed by Apnea-Tech Limited, the device manufacturers, so that it can be compared to the data captured by the standard sleep apnoea test.

Conditions

Sleep Apnea

Outcome Measures

Primary Outcomes (1)

• Correlation Between the Trial Device and an Established Device

  Exploratory study to look for correlation between the Apnoea Hyopopnea index (AHI) as measured by the Trial device (ApneScan) to the AHI measured by NOX T3 device (Standard Sleep home diagnostic kit). Both devices were worn concurrently overnight at home to allow for a data comparison.

  2 months

Secondary Outcomes (2)

• Severity of Sleep Apnoea

  2 months

• Severity of Hypopnoea

  2 months

Other Outcomes (1)

• Comparison Between Sleep Apnoea Devices

  2 months

Study Arms (1)

Sleep disorder patients

OTHER

The study participants have been referred by a clinician to the sleep clinic for diagnosis of a sleep disorder, possibly sleep apnoea.

Device: Apne-Scan DC1 device

Interventions

Apne-Scan DC1 device DEVICE

The primary objective of this exploratory study is to assess Apnea-Tech's UKCA Class I Apne-Scan DC1 sleep apnoea screening device in assisting a clinical diagnosis of sleep apnoea in comparison to standard sleep apnoea test devices (ResMed NOX T3 and Phillips Alice Night One).

Sleep disorder patients

Eligibility Criteria

• Age: 18 Years - 75 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Have been referred by a clinician to the sleep clinic for diagnosis of a sleep disorder, possibly sleep apnoea.
• Be about to be screened for possible sleep apnoea using a standard sleep apnoea test device.
• Be between the ages of 18 and 75 and have provided informed consent for the study

You may not qualify if:

• Have not been referred by a clinician to a sleep clinic for diagnostic tests for sleep disorders other than for possible sleep apnoea.
• Cannot tolerate wearing a mask overnight.
• Cannot remove a mask should they become distressed.
• Are not capable of understanding the English language version of Apne-Scan's Instructions For Use (IFU).
• Are under the age of 18 years old or over the age of 75 years old.
• Are not capable of giving informed consent

Sponsors & Collaborators

• University Hospitals of North Midlands NHS Trust: lead

Study Sites (1)

University Hospitals of North Midlands NHS Trust

Stoke-on-Trent, United Kingdom

Location

MeSH Terms

Conditions

Sleep Apnea Syndromes

Condition Hierarchy (Ancestors)

Apnea; Respiration Disorders; Respiratory Tract Diseases; Sleep Disorders, Intrinsic; Dyssomnias; Sleep Wake Disorders; Nervous System Diseases

Results Point of Contact

• Title: Aviva Ogbolosingha
• Organization: University Hospitals of North Midlands NHS Trust

aviva.ogbolosingha@uhnm.nhs.uk

01782 675380

Publication Agreements

• PI is Sponsor Employee: Yes

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: DIAGNOSTIC
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Model Details: Participants will have been referred to the sleep clinic at Royal Stoke Hospital for a diagnosis of a possible sleep disorder, possibly sleep apnoea. If they enrol in the study the participants will be asked to wear the Apne-Scan DC1 device to changing pressures in the user's breathing whilst asleep.

Study Record Dates

• First Submitted: September 6, 2023
• First Posted: September 22, 2023
• Study Start: March 26, 2024
• Primary Completion: August 31, 2024
• Study Completion: November 4, 2025
• Last Updated: June 30, 2026
• Results First Posted: May 13, 2026

Record last verified: 2026-06

Data Sharing

• IPD Sharing: Will not share

Locations

GB (1)